# Lungpacer Medical USA Inc.

Canonical: https://abierto.us/vendors/lungpacer-medical-usa-inc-em2bl19aalm8

- UEI: EM2BL19AALM8
- CAGE: 8K9A8
- Location: Exton, PA
- Awards in window: 1 (3 transactions), $0 obligated, May 2, 2025 to August 12, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00021 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Lungpacer Medical USA INC Lung-Protective Effects of Transvenous Diaphragm Activation in Patients with Ards Aoi #12: Mitigating Long-Term Effects (Mile) of Respiratory Distress. https://www.usaspending.gov/award/CONT_AWD_75A50123C00021_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/lungpacer-medical-usa-inc-em2bl19aalm8.